GlaxoSmithKline Pakistan Limited (PSX:GLAXO)

GlaxoSmithKline Pakistan Balance Sheet

Financials in millions PKR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7,007	6,513	3,611	4,755	7,085	5,605
Short-Term Investments	-	-	-	-	1,633	450.62
Cash & Short-Term Investments	7,007	6,513	3,611	4,755	8,719	6,055
Cash Growth	4.70%	80.39%	-24.06%	-45.47%	43.98%	125.11%
Accounts Receivable	652.27	555.14	1,028	1,585	1,316	1,204
Other Receivables	8,378	10,337	7,506	5,582	1,669	1,043
Receivables	11,213	10,947	8,587	7,217	3,043	2,299
Inventory	17,686	11,447	11,794	9,726	6,696	5,938
Prepaid Expenses	-	181.1	190.75	123	7.21	112.44
Other Current Assets	219.67	1,610	1,158	1,682	503.93	644.79
Total Current Assets	36,125	30,698	25,341	23,503	18,969	15,049
Property, Plant & Equipment	13,836	13,262	11,701	10,997	10,408	9,936
Goodwill	955.74	955.74	955.74	955.74	955.74	955.74
Other Intangible Assets	-	-	-	-	36	36
Other Long-Term Assets	50.15	50.15	50.15	27.52	22.01	22.01
Total Assets	51,047	45,055	38,131	35,542	30,455	26,072
Accounts Payable	5,506	1,089	1,616	560.52	652.17	659.75
Accrued Expenses	7,043	7,147	5,404	4,098	3,776	3,497
Short-Term Debt	-	198.63	572.93	284.14	235.75	334.67
Current Portion of Leases	16.48	27.89	35.94	16.5	20.89	7.78
Current Income Taxes Payable	1,223	1,443	68.69	936.81	1,116	-
Current Unearned Revenue	2,183	1,971	2,432	2,368	1,051	1,126
Other Current Liabilities	3,247	3,057	4,436	4,645	1,479	1,754
Total Current Liabilities	19,218	14,933	14,565	12,909	8,330	7,379
Long-Term Leases	350.96	145.76	116.04	45.42	32.71	31.56
Pension & Post-Retirement Benefits	773.99	636.36	593.71	577.8	298.89	508.62
Long-Term Deferred Tax Liabilities	972.43	1,064	1,181	957	806.63	674.97
Total Liabilities	21,315	16,779	16,455	14,489	9,469	8,594
Common Stock	3,185	3,185	3,185	3,185	3,185	3,185
Retained Earnings	25,421	23,965	17,364	16,742	16,675	13,167
Comprehensive Income & Other	1,127	1,127	1,127	1,127	1,127	1,127
Shareholders' Equity	29,732	28,277	21,676	21,053	20,987	17,478
Total Liabilities & Equity	51,047	45,055	38,131	35,542	30,455	26,072
Total Debt	367.44	372.28	724.9	346.07	289.36	374.01
Net Cash (Debt)	6,640	6,141	2,886	4,408	8,429	5,681
Net Cash Growth	1.76%	112.80%	-34.54%	-47.70%	48.37%	115.32%
Net Cash Per Share	20.85	19.28	9.06	13.84	26.47	17.84
Filing Date Shares Outstanding	318.33	318.47	318.47	318.47	318.47	318.47
Total Common Shares Outstanding	318.33	318.47	318.47	318.47	318.47	318.47
Working Capital	16,908	15,766	10,776	10,595	10,639	7,671
Book Value Per Share	93.40	88.79	68.06	66.11	65.90	54.88
Tangible Book Value	28,776	27,321	20,720	20,097	19,995	16,487
Tangible Book Value Per Share	90.40	85.79	65.06	63.11	62.78	51.77
Land	-	316.41	316.41	316.41	316.41	331.56
Buildings	-	3,102	3,080	3,001	2,928	2,883
Machinery	-	14,393	13,856	12,773	12,119	11,387
Construction In Progress	-	3,087	1,295	1,236	1,178	1,029

Source: S&P Global Market Intelligence. Standard template. Financial Sources.